Surgical Outcomes and Prognostic Factors in Patients With Diffuse Large B-cell Lymphoma-associated Metastatic Spinal Cord Compression

被引:15
作者
Han, Shuai [1 ]
Yang, Xinghai [1 ]
Jiang, Dongjie [1 ]
Zhou, Wang [1 ]
Liu, Tielong [1 ]
Yan, Wangjun [1 ]
Wang, Ting [1 ]
Cheng, Li [1 ]
Xiao, Jianru [1 ]
机构
[1] Second Mil Med Univ, Changzheng Hosp, Dept Bone Tumor Surg, Shanghai, Peoples R China
关键词
diffuse large B-cell lymphoma; metastatic spinal cord compression; prognostic factors; spinal decompression; stabilization; surgical outcomes; NON-HODGKINS-LYMPHOMA; PRIMARY BONE LYMPHOMA; CHEMOTHERAPY; CHOP;
D O I
10.1097/BRS.0000000000001511
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Study Design. A retrospective study. Objective. The aim of this study was to discuss the factors that may affect surgical outcomes of patient with diffuse large B-cell lymphoma (DLBCL)-associated metastatic spinal cord compression (MSCC). Summary of Background Data. DLBCL in the spine is rare and minimal information has been published in the literature regarding this subject. Although DLBCL is highly sensitive to both chemotherapy and radiotherapy, surgical decompression is recommended in the treatment of DLBCL-associated MSCC. However, the prognostic factors affecting surgical outcomes of patients with DLBCL-associated MSCC remain unknown. Methods. We conducted a retrospective study to investigate the impact of surgical decompression on recovery from neurological deficit caused by DLBCL-associated MSCC. Univariate and multivariate analyses were performed to identify prognostic factors for overall survival of spinal DLBCL. The survival rate was estimated by the Kaplan-Meier method, and differences were analyzed by the log-rank test. Factors with P values of 0.1 or less were subjected to multivariate analysis for survival rate by multivariate Cox proportional hazards analysis. Results. A total of 37 patients with spinal DLBCL from 2003 to 2014 were included in the study. International Prognostic Index (IPI) (0-1/2-5), duration of preoperative symptoms (<= 2m/>2m), and lactate dehydrogenase (normal/abnormal) were suggested as the potential prognostic factors through univariate analysis. However, as they were submitted to the multivariate Cox regression model, only IPI and duration of preoperative symptoms were found as independent prognostic factors. Conclusion. Surgical decompression improves recovery from neurological deficit. Patient IPI score plays an important role in decision making for surgical intervention, as it affects the length of survival and functional outcome. Patients with duration of preoperative symptoms no more than 2 months confer a very poor prognosis.
引用
收藏
页码:E943 / E948
页数:6
相关论文
共 50 条
  • [21] Management Strategies and Outcomes for Very Elderly Patients With Diffuse Large B-Cell Lymphoma
    Chihara, Dai
    Westin, Jason R.
    Oki, Yasuhiro
    Ahmed, Mohamed A.
    Do, Bryan
    Fayad, Luis E.
    Hagemeister, Fredrick B.
    Romaguera, Jorge E.
    Fanale, Michelle A.
    Lee, Hun J.
    Turturro, Francesco
    Samaniego, Felipe
    Neelapu, Sattva S.
    Rodriguez, M. Alma
    Fowler, Nathan H.
    Wang, Michael
    Davis, Richard E.
    Nastoupil, Loretta J.
    CANCER, 2016, 122 (20) : 3145 - 3151
  • [22] Prognostic Factors in Elderly Patients with Diffuse Large B-Cell Lymphoma and Their Treatment Results
    Adiyaman, Suleyman Cem
    Alacacioglu, Inci
    Danyeli, Ayca Ersen
    Turkyilmaz, Dogus
    Sevindik, Omur Gokmen
    Demirkan, Fatih
    Piskin, Ozden
    Ozcan, Mehmet Ali
    Undar, Bulent
    Ozkal, Sermin
    Ozsan, Guner Hayri
    TURKISH JOURNAL OF HEMATOLOGY, 2019, 36 (02) : 81 - 87
  • [23] Prognostic Nomogram for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma
    Han, Ying
    Yang, Jianliang
    Liu, Peng
    He, Xiaohui
    Zhang, Changgong
    Zhou, Shengyu
    Zhou, Liqiang
    Qin, Yan
    Song, Yongwen
    Sun, Yan
    Shi, Yuankai
    ONCOLOGIST, 2019, 24 (11) : E1251 - E1261
  • [24] Analysis of prognostic factors in patients with newly diagnosed diffuse large B-cell lymphoma and skeletal involvement
    Lehners, Nicola
    Kraemer, Isabelle
    Saadati, Maral
    Benner, Axel
    Ho, Anthony D.
    Witzens-Harig, Mathias
    BMC CANCER, 2017, 17
  • [25] Epstein-Barr virus as a prognostic factor in de novo nodal diffuse large B-cell lymphoma
    Morales, Domingo
    Beltran, Brady
    De Mendoza, Fernando Hurtado
    Riva, Luis
    Yabar, Alejandro
    Quinones, Pilar
    Butera, James N.
    Castillo, Jorge
    LEUKEMIA & LYMPHOMA, 2010, 51 (01) : 66 - 72
  • [26] Prognostic factors for patients with diffuse large B cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation in the positron emission tomography era
    Armand, Philippe
    Welch, Sarah
    Kim, Haesook T.
    LaCasce, Ann S.
    Jacobsen, Eric D.
    Davids, Matthew S.
    Jacobson, Caron
    Fisher, David C.
    Brown, Jennifer R.
    Coughlin, Erin
    Freedman, Arnold S.
    Chen, Yi-Bin
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 160 (05) : 608 - 617
  • [27] Predictive and Prognostic Molecular Factors in Diffuse Large B-Cell Lymphomas
    Pileri, Stefano A.
    Tripodo, Claudio
    Melle, Federica
    Motta, Giovanna
    Tabanelli, Valentina
    Fiori, Stefano
    Vegliante, Maria Carmela
    Mazzara, Saveria
    Ciavarella, Sabino
    Derenzini, Enrico
    CELLS, 2021, 10 (03) : 1 - 15
  • [28] Prognostic Factors and Treatment Efficacy in Patients with Primary Diffuse Large B-cell Lymphoma of the Bone: Single Institute Experience Over 11 Years
    Liu, Yao-Chung
    Gau, Jyh-Pyng
    Yu, Yuan-Bin
    Hong, Ying-Chung
    Yen, Chueh-Chuan
    Liu, Chun-Yu
    Chao, Ta-Chung
    Hsiao, Liang-Tsai
    Liu, Jin-Hwang
    Chiou, Tzeon-Jye
    Tzeng, Cheng-Hwai
    INTERNAL MEDICINE, 2014, 53 (02) : 95 - 101
  • [29] Salvage chemotherapy and autologous stem cell transplant in primary refractory diffuse large B-cell lymphoma: outcomes and prognostic factors
    Telio, David
    Fernandes, Kim
    Ma, Clement
    Tsang, Richard
    Keating, Armand
    Crump, Michael
    Kuruvilla, John
    LEUKEMIA & LYMPHOMA, 2012, 53 (05) : 836 - 841
  • [30] Prognostic significance of progranulin and B7-H4 in patients with diffuse large B-cell lymphoma
    Elkholy, Rasha A.
    Allam, Alzahraa A.
    Elattar, Shimaa H.
    Elkady, Asmaa M.
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2019, 44 (02) : 82 - 90